Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-03-02 @ 4:11 AM
Study NCT ID:
NCT02940860
Status:
COMPLETED
Last Update Posted:
2020-10-06
First Post:
2016-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
Sponsor:
Pharmacosmos A/S
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Iron Deficiency Anaemia | View |
| None | Iron Deficiency Anemia | View |
| None | IDA | View |
| None | Chronic Kidney Disease | View |
| None | CKD | View |
| None | Iron isomaltoside | View |
| None | Ferric derisomaltose | View |
| None | Monofer | View |
| None | Monoferric | View |
| None | Monover | View |
| None | Monofar | View |
| None | Monoferro | View |